Gliotoxin is a sulfur-containing antibiotic produced by several species of fungi, some of which are pathogens of humans such as Aspergillus, and also by species of Trichoderma, and Penicillium. Previously gliotoxin has also been reported in yeasts of the genus Candida; results of a recent study of 100 clinical Candida isolates, however, have cast doubt on the occurrence of this metabolite in this group of fungi. 1 It was originally isolated from Gliocladium fimbriatum, and was named accordingly. It is an epipolythiodioxopiperazine metabolite. Gliotoxin possesses immunosuppressive properties as it may suppress and cause apoptosis in certain types of cells of the immune system, including neutrophils, eosinophils, granulocytes, macrophages, and thymocytes. It also acts as an inhibitor of farnesyl transferase. It noncompetitively inhibits the chymotrypsin-like activity of the 20S proteasome. In vivo it displays anti-inflammatory activity.2 It acts by blocking thiol groups in the cell membranes. References
External linksGliotoxin product page from Fermentek
| | |||||||||||||||||||||||||||